価格表

在庫・価格 : 2024年06月18日 08時08分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-ChREBP, Rabbit-Poly
データシート
NB400-135 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 ml ¥103,000
(未発注)
追加

在庫・価格 : 2024年06月18日 08時08分 現在

Anti-ChREBP, Rabbit-Poly

  • 商品コード:NB400-135
  • メーカー:NOV
  • 包装:0.1ml
  • 価格: ¥103,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Xu J et al. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist. J. Biol. Chem. 2006 Jul;281(27):18351-62
Xu J et al
2006/01/01
PubMed
2 Wang Y et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 2006 Sep;47(9):2028-41
Wang Y et al
2006/01/01
PubMed
3 Dentin R et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006 Aug;55(8):2159-70
Dentin R et al
2006/01/01
PubMed
4 Marmugi A et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012 Feb;55(2):395-407
Marmugi A et al
2012/01/01
PubMed
5 Vidal-Alabr坦 A et al. Liver Glucokinase(A456V) Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase. Int J Endocrinol 2011;2011:707928
Vidal-Alabr坦 A et al
2011/01/01
PubMed
6 Iizuka K et al. Rat glucagon receptor mRNA is directly regulated by glucose through transactivation of the carbohydrate response element binding protein. Biochem. Biophys. Res. Commun. 2012 Jan;417(4):1107-12
Iizuka K et al
2012/01/01
PubMed
7 Larter CZ et al. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 2012 Feb;27(2):341-50
Larter CZ et al
2012/01/01
PubMed
8 Sirek AS et al. Insulin stimulates the expression of carbohydrate response element binding protein (ChREBP) by attenuating the repressive effect of Pit-1, Oct-1/Oct-2, and Unc-86 homeodomain protein octamer transcription factor-1. Endocrinology 2009 Aug;1
Sirek AS et al
2009/01/01
PubMed
9 Wang Y et al. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J. Lipid Res. 2008 Jul;49(7):1538-52
Wang Y et al
2008/01/01
PubMed
10 Shao W et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE 2012;7(1):e28784
Shao W et al
2012/01/01
PubMed
11 Kim HJ et al. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am. J. Physiol. Renal Physiol. 2009 Jun;296(6):F1297-306
Kim HJ et al
2009/01/01
PubMed
12 Bu SY et al. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J. Biol. Chem. 2009 Oct;284(44):30474-83
Bu SY et al
2009/01/01
PubMed
13 Burke SJ et al. cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4alpha, and CBP. FASEB J. 2009 Sep;23(9):2855-65
Burke SJ et al
2009/01/01
PubMed
14 Tong X et al. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 2009 Dec;106(51):21660-5
Tong X et al
2009/01/01
PubMed
15 Iizuka K et al. Krüppel-like factor-10 is directly regulated by carbohydrate response element-binding protein in rat primary hepatocytes. Biochem. Biophys. Res. Commun. 2011 Sep;412(4):638-43
Iizuka K et al
2011/01/01
PubMed
16 Jeong YS et al. Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression. PLoS ONE 2011;6(7):e22544
Jeong YS et al
2011/01/01
PubMed
17 Erhuma A et al. Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat. Am. J. Physiol. Endocrinol. Metab. 2007 Jun;292(6):E1702-14
Erhuma A et al
2007/01/01
PubMed
18 Aneja KK et al. The presence of distal and proximal promoters for rat mitochondrial glycerol-3-phosphate acyltransferase. Arch. Biochem. Biophys. 2008 Feb;470(1):35-43
Aneja KK et al
2008/01/01
PubMed
19 Arden C et al. Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis. Diabetes 2011 Dec;60(12):3110-20
Arden C et al
2011/01/01
PubMed
20 Uebanso T et al. Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor? PLoS ONE 2011;6(8):e22976
Uebanso T et al
2011/01/01
PubMed
21 Kang YJ et al. Trichinella spiralis infection induces angiogenic factor thymosin β4 expression. Vet. Parasitol. 2011 Sep;181(2-4):222-8
Kang YJ et al
2011/01/01
PubMed
22 Zhang P et al. c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes. Mol. Endocrinol. 2010 Jun;24(6):1274-86
Zhang P et al
2010/01/01
PubMed
23 Boergesen M et al. ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells. J. Biol. Chem. 2011 Apr;286(15):13214-25
Boergesen M et al
2011/01/01
PubMed
24 Inoue J et al. Identification of MIG12 as a mediator for stimulation of lipogenesis by LXR activation. Mol. Endocrinol. 2011 Jun;25(6):995-1005
Inoue J et al
2011/01/01
PubMed
25 Moon YA et al. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J. Lipid Res. 2009 Mar;50(3):412-23
Moon YA et al
2009/01/01
PubMed
26 Dentin R et al. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J. Hepatol. 2012 Jan;56(1):199-209
Dentin R et al
2012/01/01
Applications: WB, Species: Mouse PubMed
27 Perttil辰 J et al. PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis. Am. J. Physiol. Endocrinol. Metab. 2012 May;302(9):E1063-9
Perttil辰 J et al
2012/01/01
Applications: ChIP, Species: Human PubMed
28 Hagiwara A et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 2012 May;15(5):725-38
Hagiwara A et al
2012/01/01
Applications: WB, Species: Mouse PubMed
29 Benhamed F et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J. Clin. Invest. 2012 Jun;122(6):2176-94
Benhamed F et al
2012/01/01
Species: Mouse, Applications: WB PubMed
30 Oosterveer MH et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver. J. Clin. Invest. 2012 Aug;122(8):2817-26
Oosterveer MH et al
2012/01/01
Species: Mouse, Applications: WB PubMed
31 Feingold KR et al. Endotoxin, zymosan, and cytokines decrease the expression of the transcription factor, carbohydrate response element binding protein, and its target genes. Innate Immun 2011 Apr;17(2):174-82
Feingold KR et al
2011/01/01
Applications: WB PubMed
32 Arden C et al. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochem. J. 2012 Apr;443(1):111-23
Arden C et al
2012/01/01
Applications: ChIP, ICC/IF PubMed
33 Guinez C et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 2011 May;60(5):1399-413
Guinez C et al
2011/01/01
Applications: ChIP, WB PubMed
34 Zhang YK et al. Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. Toxicol. Appl. Pharmacol. 2012 Nov;264(3):305-14
Zhang YK et al
2012/01/01
Applications: WB PubMed
35 Ido-Kitamura Y et al. Hepatic FoxO1 Integrates Glucose Utilization and Lipid Synthesis through Regulation of Chrebp O-Glycosylation. PLoS ONE 2012;7(10):e47231
Ido-Kitamura Y et al
2012/01/01
Species: Mouse, Applications: IP, WB PubMed
36 Jin K et al. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol. Dial. Transplant. 2012 Oct;
Jin K et al
2012/01/01
Species: Rat, Applications: WB PubMed
37 Petrie JL et al. Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter. Mol. Cell. Biol. 2013 Feb;33(4):725-38
Petrie JL et al
2013/01/01
Species: Rat, Applications: ChIP PubMed
38 Caron S et al. Farnesoid x receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes. Mol. Cell. Biol. 2013 Jun;33(11):2202-11
Caron S et al
2013/01/01
Species: Human, Applications: ChIP PubMed
39 Liu Y et al. Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver. J Am Heart Assoc 2013 Apr;2(2):e000093
Liu Y et al
2013/01/01
Species: Mouse, Applications: WB PubMed
40 Han S et al. Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome. Am J Transl Res 2013;5(2):246-53
Han S et al
2013/01/01
Species: Rat, Applications: WB PubMed
41 Liu C et al. Oleanolic Acid diminishes liquid fructose-induced Fatty liver in rats: role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo Fatty Acid synthesis. Evid Based Complement
Liu C et al
2013/01/01
Species: Rat, Applications: WB PubMed
42 Burke SJ et al. cAMP prevents glucose-mediated modifications of histone H3 and recruitment of the RNA polymerase II holoenzyme to the L-PK gene promoter. J. Mol. Biol. 2009 Sep;392(3):578-88
Burke SJ et al
2009/01/01
Species: Rat, Applications: ChIP PubMed
43 Fukasawa M et al. Coordinate regulation/localization of the carbohydrate responsive binding protein (ChREBP) by two nuclear export signal sites: discovery of a new leucine-rich nuclear export signal site. Biochem. Biophys. Res. Commun. 2010 Jan;391(2):116
Fukasawa M et al
2010/01/01
Species: Rat, Applications: EMSA PubMed
44 Jo SH et al. Txnip contributes to impaired glucose tolerance by upregulating the expression of genes involved in hepatic gluconeogenesis in mice. Diabetologia 2013 Dec;56(12):2723-32
Jo SH et al
2013/01/01
Species: Mouse, Applications: ChIP PubMed
45 Chambers KT et al. PGC-1β and ChREBP partner to cooperatively regulate hepatic lipogenesis in a glucose concentration-dependent manner. Mol Metab 2013;2(3):194-204
Chambers KT et al
2013/01/01
Species: Mouse, Applications: WB, ChIP PubMed
46 Wu L et al. Flightless I homolog negatively regulates ChREBP activity in cancer cells. Int. J. Biochem. Cell Biol. 2013 Nov;45(11):2688-97
Wu L et al
2013/01/01
Species: Human, Applications: IP, WB PubMed
47 Liu L et al. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. J Ethnopharmacol 2013 Dec;150(3):1045-52
Liu L et al
2013/01/01
PubMed
48 Xing X et al. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver. Toxicol. Appl. Pharmacol. 2014 Oct;280(2):207-15
Xing X et al
2014/01/01
Species: Rat, Applications: WB PubMed
49 Chang ML et al. High glucose activates ChREBP-mediated HIF-1α and VEGF expression in human RPE cells under normoxia. Adv. Exp. Med. Biol. 2014;801:609-21
Chang ML et al
2014/01/01
Species: Human, Applications: ChIP, WB, ICC/IF PubMed
50 Kaadige MR et al. MondoA-Mlx Transcriptional Activity Is Limited by mTOR-MondoA Interaction. Mol. Cell. Biol. 2015 Jan;35(1):101-10
Kaadige MR et al
2015/01/01
Species: Human, Applications: WB PubMed
51 Gupta M et al. Maternal magnesium deficiency in mice leads to maternal metabolic dysfunction and altered lipid metabolism with fetal growth restriction. Mol. Med. 2014;20:332-40
Gupta M et al
2014/01/01
Species: Mouse, Applications: WB PubMed
52 Cort辿s VA et al. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors. J. Lipid Res. 2014 Feb;55(2):276-88
Cort辿s VA et al
2014/01/01
Species: Mouse, PubMed
53 Bindesb淡ll C et al. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity. J. Lipid Res. 2015 Apr;56(4):771-85
Bindesb淡ll C et al
2015/01/01
Species: Mouse, PubMed
54 Marmier S et al. Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology 2015 Mar;
Marmier S et al
2015/01/01
Species: Human, Applications: WB, IP PubMed
55 Poungvarin N et al. Genome-Wide Analysis of ChREBP Binding Sites on Male Mouse Liver and White Adipose Chromatin. Endocrinology 2015 Jun;156(6):1982-94
Poungvarin N et al
2015/01/01
Species: Mouse, Applications: ChIP PubMed
56 Li X et al. New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells. Mol. Endocrinol. 2015 Aug;29(8):1184-94
Li X et al
2015/01/01
Species: Human, Mouse, Applications: ICC/IF PubMed
57 Cha-Molstad H et al. Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells. J. Biol. Chem. 2009 Jun;284(25):16898-905
Cha-Molstad H et al
2009/01/01
PubMed
58 Butcher AJ et al. N-methyl-D-aspartate receptors mediate the phosphorylation and desensitization of muscarinic receptors in cerebellar granule neurons. J. Biol. Chem. 2009 Jun;284(25):17147-56
Butcher AJ et al
2009/01/01
Species: Mouse PubMed
59 Nuotio-Antar AM et al. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance. Endocrinology 2015 Nov;156(11):4020-32
Nuotio-Antar AM et al
2015/01/01
Species: Mouse, Applications: WB PubMed
60 Ferreira DM et al. Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains. Microb. Pathog. 2009 Sep;47(3):157-63
Ferreira DM et al
2009/01/01
Applications: WB PubMed
61 Adamson AW et al. Hepatocyte nuclear factor-4alpha contributes to carbohydrate-induced transcriptional activation of hepatic fatty acid synthase. Biochem. J. 2006 Oct;399(2):285-95
Adamson AW et al
2006/01/01
Applications: WB PubMed
62 Pedersen KB et al. Glucose induces expression of rat pyruvate carboxylase through a carbohydrate response element in the distal gene promoter. Biochem. J. 2010 Mar;426(2):159-70
Pedersen KB et al
2010/01/01
Species: Rat PubMed
63 Yu FX et al. Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate. J. Biol. Chem. 2010 Aug;285(33):25822-30
Yu FX et al
2010/01/01
Species: Human PubMed
64 Marmugi A et al. Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way. Toxicol. Appl. Pharmacol. 2016 Jul;303:90-100
Marmugi A et al
2016/01/01
PubMed
65 Kitsunai H et al. High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells. Physiol Rep 2016 Mar;4(6)
Kitsunai H et al
2016/01/01
PubMed
66 Zhang Z et al. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. Sci Rep 2016;6:20848
Zhang Z et al
2016/01/01
PubMed
67 Tang Y et al. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Nat Commun 2016;7:11365
Tang Y et al
2016/01/01
PubMed
68 Witte N et al. The Glucose Sensor ChREBP Links De Novo Lipogenesis to PPARγ Activity and Adipocyte Differentiation. Endocrinology 2015 Nov;156(11):4008-19
Witte N et al
2015/01/01
PubMed
69 Chelimo K et al. Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1. PLoS ONE 2011;6(9):e24852
Chelimo K et al
2011/01/01
PubMed
70 Miller SD et al. Reduced impact logging minimally alters tropical rainforest carbon and energy exchange. Proc. Natl. Acad. Sci. U.S.A. 2011 Nov;108(48):19431-5
Miller SD et al
2011/01/01
PubMed
71 Krishnamoorthy N et al. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat. Med. 2008 May;14(5):565-73
Krishnamoorthy N et al
2008/01/01
PubMed
72 Trabelsi MS et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun 2015;6:7629
Trabelsi MS et al
2015/01/01
PubMed
73 Eckert DT et al. Detailed molecular analysis of the induction of the L-PK gene by glucose. Biochem. Biophys. Res. Commun. 2008 Jul;372(1):131-6
Eckert DT et al
2008/01/01
PubMed
74 Xiang Y et al. Crystal structure of a virus-encoded putative glycosyltransferase. J. Virol. 2010 Dec;84(23):12265-73
Xiang Y et al
2010/01/01
PubMed
75 Kim GY et al. Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy. Hum. Mol. Genet. 2017 05;26(10):1890-1899
Kim GY et al
2017/01/01
Species: Mouse, Applications: WB PubMed
76 Sanchez-Gurmaches J et al. Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis. Cell Metab. 2018 Jan;27(1):195-209.e6
Sanchez-Gurmaches J et al
2018/01/01
Species: Mouse PubMed
77 Janssens S et al. An In Vivo Magnetic Resonance Spectroscopy Study of the Effects of Caloric and Non-Caloric Sweeteners on Liver Lipid Metabolism in Rats. Nutrients 2017 May;9(5)
Janssens S et al
2017/01/01
Species: Rat, Applications: WB PubMed
78 Singh KB et al. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism. Carcinogenesis 2018 May;39(6):826-837
Singh KB et al
2018/01/01
Species: Mouse, Applications: PubMed
79 Schmidt SF et al. Integrative Genomics Outlines a Biphasic Glucose Response and a ChREBP-RORγ Axis Regulating Proliferation in β Cells. Cell Rep 2016 08;16(9):2359-72
Schmidt SF et al
2016/01/01
Species: Human, Applications: ChIP PubMed
80 Harris K et al. The effects of prenatal metformin on obesogenic diet-induced alterations in maternal and fetal fatty acid metabolism. Nutr Metab (Lond) 2016;13(1):55
Harris K et al
2016/01/01
Species: Rat, Applications: WB PubMed
81 Al-Oanzi ZH et al. Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes. Diabetes Obes Metab 2017 08;19(8):1078-1087
Al-Oanzi ZH et al
2017/01/01
Species: Rat, Applications: ChIP PubMed
82 Bricambert J et al. The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. Nat Commun 2018 05;9(1):2092
Bricambert J et al
2018/01/01
Species: Mouse, Applications: WB PubMed
83 Linden AG et al. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J. Lipid Res. 2018 03;59(3):475-487
Linden AG et al
2018/01/01
Species: Mouse, Applications: WB PubMed
84 Fan Q et al. LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice. Nutrients 2017 Jun;9(7)
Fan Q et al
2017/01/01
Species: Mouse, Applications: WB PubMed
85 Kim YS et al. Aralia elata (Miq) Seem Extract Decreases O-GlcNAc Transferase Expression and Retinal Cell Death in Diabetic Mice. J Med Food 2017 Oct;20(10):989-1001
Kim YS et al
2017/01/01
Species: Mouse, Applications: WB PubMed
86 Cho JH et al. Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia. PLoS Genet. 2017 May;13(5):e1006819
Cho JH et al
2017/01/01
Species: Mouse, Applications: IHC-P PubMed
87 Cao W et al. Dual effects of fructose on ChREBP and FoxO1/3α are responsible for AldoB up-regulation and vascular remodelling. Clin. Sci. 2017 02;131(4):309-325
Cao W et al
2017/01/01
WB PubMed
88 Kumar A et al. Activation of Nrf2 Is Required for Normal and ChREBPα-Augmented Glucose-Stimulated β-Cell Proliferation. Diabetes 2018 08;67(8):1561-1575
Kumar A et al
2018/01/01
Species: Human, Applications: PubMed
89 Kim MS et al. ChREBP regulates fructose-induced glucose production independently of insulin signaling. J. Clin. Invest. 2016 11;126(11):4372-4386
Kim MS et al
2016/01/01
Species: Mouse, Applications: WB PubMed
90 Na TY et al. The trisaccharide raffinose modulates epidermal differentiation through activation of liver X receptor. Sci Rep 2017 03;7:43823
Na TY et al
2017/01/01
Species: Human, Applications: ChIP PubMed
91 Iroz A et al. A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response. Cell Rep 2017 Oct;21(2):403-416
Iroz A et al
2017/01/01
Species: Mouse, Applications: ChIP PubMed
92 Softic S et al. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J. Clin. Invest. 2017 Nov;127(11):4059-4074
Softic S et al
2017/01/01
Species: Mouse, Applications: WB PubMed
93 Kwon JH et al. Liver-directed gene therapy for murine glycogen storage disease type Ib. Hum. Mol. Genet. 2017 11;26(22):4395-4405
Kwon JH et al
2017/01/01
Species: Mouse, Applications: WB PubMed
94 Kim M et al. Intestinal, but not hepatic, ChREBP is required for fructose tolerance. JCI Insight 2017 Dec;2(24)
Kim M et al
2017/01/01
Species: Mouse, Applications: ChIP, WB PubMed
95 Heidenreich S et al. Retinol saturase coordinates liver metabolism by regulating ChREBP activity. Nat Commun 2017 08;8(1):384
Heidenreich S et al
2017/01/01
Species: Mouse, Applications: WB PubMed
96 Kim YS et al. Metformin protects against retinal cell death in diabetic mice. Biochem. Biophys. Res. Commun. 2017 10;492(3):397-403
Kim YS et al
2017/01/01
Species: Mouse, Applications: PubMed
97 Zhao C et al. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. Mol Metab 2019 11;29:145-157
Zhao C et al
2019/01/01
PubMed
98 Irimia JM et al. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice. J Biol Chem 2017 06;292(25):10455-10464
Irimia JM et al
2017/01/01
PubMed
99 Long J et al. Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1. J Biol Chem 2020 11;295(47):15840-15852
Long J et al
2020/01/01
PubMed
100 Lei Y et al. Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation. Sci Rep 2020 03;10(1):4233
Lei Y et al
2020/01/01
PubMed
101 Fan Q et al. LXRα Regulates ChREBPα Transactivity in a Target Gene-Specific Manner through an Agonist-Modulated LBD-LID Interaction. Cells 2020 05;9(5)
Fan Q et al
2020/01/01
PubMed
102 McMurphy TB et al. Hepatic Expression of Adenovirus 36 E4ORF1 Improves Glycemic Control and Promotes Glucose Metabolism Through AKT Activation. Diabetes 2017 02;66(2):358-371
McMurphy TB et al
2017/01/01
PubMed
103 Tong X et al. DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1. Metabolism 2020 06;107:154222
Tong X et al
2020/01/01
PubMed
104 Bagchi DP et al. Wntless regulates lipogenic gene expression in adipocytes and protects against diet-induced metabolic dysfunction. Mol Metab 2020 09;39:100992
Bagchi DP et al
2020/01/01
PubMed
105 Wei C et al. ChREBP-β regulates thermogenesis in brown adipose tissue. J Endocrinol 2020 06;245(3):343-356
Wei C et al
2020/01/01
PubMed
106 Youn DY et al. The Mediator complex kinase module is necessary for fructose regulation of liver glycogen levels through induction of glucose-6-phosphatase catalytic subunit (G6pc). Mol Metab 2021 06;48:101227
Youn DY et al
2021/01/01
PubMed
107 Vel叩zquez-Villegas L et al. ChREBP downregulates SNAT2 amino acid transporter expression through interactions with SMRT in response to a high-carbohydrate diet. Am J Physiol Endocrinol Metab 2021 01;320(1):E102-E112
Vel叩zquez-Villegas L et al
2021/01/01
PubMed
108 Liu Y et al. Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles. Sci Rep 2021 Jun;11(1):11907
Liu Y et al
2021/01/01
PubMed
109 Lu Y et al. ERα down-regulates carbohydrate responsive element binding protein and decreases aerobic glycolysis in liver cancer cells. J Cell Mol Med 2021 04;25(7):3427-3436
Lu Y et al
2021/01/01
PubMed
110 Katz LS et al. T3 and Glucose Coordinately Stimulate ChREBP-Mediated Ucp1 Expression in Brown Adipocytes From Male Mice. Endocrinology 2018 01;159(1):557-569
Katz LS et al
2018/01/01
PubMed
111 Mori H et al. The molecular and metabolic program by which white adipocytes adapt to cool physiologic temperatures. PLoS Biol 2021 05;19(5):e3000988
Mori H et al
2021/01/01
PubMed
112 Gutierrez JA et al. Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction. Mol Metab 2021 06;48:101196
Gutierrez JA et al
2021/01/01
PubMed
113 Hsiao WY et al. The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development. Cell Rep 2020 10;33(1):108223
Hsiao WY et al
2020/01/01
PubMed
114 Heidenreich S et al. The glucose-sensing transcription factor ChREBP is targeted by proline hydroxylation. J Biol Chem 2020 12;295(50):17158-17168
Heidenreich S et al
2020/01/01
PubMed
115 Schlein C et al. Endogenous Fatty Acid Synthesis Drives Brown Adipose Tissue Involution. Cell Rep 2021 01;34(2):108624
Schlein C et al
2021/01/01
PubMed
116 Chen N et al. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy. J Diabetes Complications 2021 Dec;35(12):108050
Chen N et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Xu J et al. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist. J. Biol. Chem. 2006 Jul;281(27):18351-62
    Xu J et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wang Y et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 2006 Sep;47(9):2028-41
    Wang Y et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Dentin R et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006 Aug;55(8):2159-70
    Dentin R et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Marmugi A et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012 Feb;55(2):395-407
    Marmugi A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Vidal-Alabr坦 A et al. Liver Glucokinase(A456V) Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase. Int J Endocrinol 2011;2011:707928
    Vidal-Alabr坦 A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Iizuka K et al. Rat glucagon receptor mRNA is directly regulated by glucose through transactivation of the carbohydrate response element binding protein. Biochem. Biophys. Res. Commun. 2012 Jan;417(4):1107-12
    Iizuka K et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Larter CZ et al. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 2012 Feb;27(2):341-50
    Larter CZ et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Sirek AS et al. Insulin stimulates the expression of carbohydrate response element binding protein (ChREBP) by attenuating the repressive effect of Pit-1, Oct-1/Oct-2, and Unc-86 homeodomain protein octamer transcription factor-1. Endocrinology 2009 Aug;1
    Sirek AS et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Wang Y et al. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J. Lipid Res. 2008 Jul;49(7):1538-52
    Wang Y et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Shao W et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE 2012;7(1):e28784
    Shao W et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Kim HJ et al. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am. J. Physiol. Renal Physiol. 2009 Jun;296(6):F1297-306
    Kim HJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Bu SY et al. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J. Biol. Chem. 2009 Oct;284(44):30474-83
    Bu SY et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Burke SJ et al. cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4alpha, and CBP. FASEB J. 2009 Sep;23(9):2855-65
    Burke SJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Tong X et al. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 2009 Dec;106(51):21660-5
    Tong X et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Iizuka K et al. Krüppel-like factor-10 is directly regulated by carbohydrate response element-binding protein in rat primary hepatocytes. Biochem. Biophys. Res. Commun. 2011 Sep;412(4):638-43
    Iizuka K et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Jeong YS et al. Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression. PLoS ONE 2011;6(7):e22544
    Jeong YS et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Erhuma A et al. Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat. Am. J. Physiol. Endocrinol. Metab. 2007 Jun;292(6):E1702-14
    Erhuma A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Aneja KK et al. The presence of distal and proximal promoters for rat mitochondrial glycerol-3-phosphate acyltransferase. Arch. Biochem. Biophys. 2008 Feb;470(1):35-43
    Aneja KK et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Arden C et al. Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis. Diabetes 2011 Dec;60(12):3110-20
    Arden C et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Uebanso T et al. Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor? PLoS ONE 2011;6(8):e22976
    Uebanso T et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Kang YJ et al. Trichinella spiralis infection induces angiogenic factor thymosin β4 expression. Vet. Parasitol. 2011 Sep;181(2-4):222-8
    Kang YJ et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Zhang P et al. c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes. Mol. Endocrinol. 2010 Jun;24(6):1274-86
    Zhang P et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Boergesen M et al. ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells. J. Biol. Chem. 2011 Apr;286(15):13214-25
    Boergesen M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Inoue J et al. Identification of MIG12 as a mediator for stimulation of lipogenesis by LXR activation. Mol. Endocrinol. 2011 Jun;25(6):995-1005
    Inoue J et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Moon YA et al. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J. Lipid Res. 2009 Mar;50(3):412-23
    Moon YA et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Dentin R et al. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J. Hepatol. 2012 Jan;56(1):199-209
    Dentin R et al
    2012/01/01
  • 備考:
    Applications: WB, Species: Mouse
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Perttil辰 J et al. PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis. Am. J. Physiol. Endocrinol. Metab. 2012 May;302(9):E1063-9
    Perttil辰 J et al
    2012/01/01
  • 備考:
    Applications: ChIP, Species: Human
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Hagiwara A et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 2012 May;15(5):725-38
    Hagiwara A et al
    2012/01/01
  • 備考:
    Applications: WB, Species: Mouse
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Benhamed F et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J. Clin. Invest. 2012 Jun;122(6):2176-94
    Benhamed F et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Oosterveer MH et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver. J. Clin. Invest. 2012 Aug;122(8):2817-26
    Oosterveer MH et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Feingold KR et al. Endotoxin, zymosan, and cytokines decrease the expression of the transcription factor, carbohydrate response element binding protein, and its target genes. Innate Immun 2011 Apr;17(2):174-82
    Feingold KR et al
    2011/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Arden C et al. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochem. J. 2012 Apr;443(1):111-23
    Arden C et al
    2012/01/01
  • 備考:
    Applications: ChIP, ICC/IF
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Guinez C et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 2011 May;60(5):1399-413
    Guinez C et al
    2011/01/01
  • 備考:
    Applications: ChIP, WB
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Zhang YK et al. Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. Toxicol. Appl. Pharmacol. 2012 Nov;264(3):305-14
    Zhang YK et al
    2012/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Ido-Kitamura Y et al. Hepatic FoxO1 Integrates Glucose Utilization and Lipid Synthesis through Regulation of Chrebp O-Glycosylation. PLoS ONE 2012;7(10):e47231
    Ido-Kitamura Y et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: IP, WB
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Jin K et al. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol. Dial. Transplant. 2012 Oct;
    Jin K et al
    2012/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Petrie JL et al. Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter. Mol. Cell. Biol. 2013 Feb;33(4):725-38
    Petrie JL et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: ChIP
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Caron S et al. Farnesoid x receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes. Mol. Cell. Biol. 2013 Jun;33(11):2202-11
    Caron S et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ChIP
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Liu Y et al. Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver. J Am Heart Assoc 2013 Apr;2(2):e000093
    Liu Y et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Han S et al. Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome. Am J Transl Res 2013;5(2):246-53
    Han S et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Liu C et al. Oleanolic Acid diminishes liquid fructose-induced Fatty liver in rats: role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo Fatty Acid synthesis. Evid Based Complement
    Liu C et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Burke SJ et al. cAMP prevents glucose-mediated modifications of histone H3 and recruitment of the RNA polymerase II holoenzyme to the L-PK gene promoter. J. Mol. Biol. 2009 Sep;392(3):578-88
    Burke SJ et al
    2009/01/01
  • 備考:
    Species: Rat, Applications: ChIP
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Fukasawa M et al. Coordinate regulation/localization of the carbohydrate responsive binding protein (ChREBP) by two nuclear export signal sites: discovery of a new leucine-rich nuclear export signal site. Biochem. Biophys. Res. Commun. 2010 Jan;391(2):116
    Fukasawa M et al
    2010/01/01
  • 備考:
    Species: Rat, Applications: EMSA
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Jo SH et al. Txnip contributes to impaired glucose tolerance by upregulating the expression of genes involved in hepatic gluconeogenesis in mice. Diabetologia 2013 Dec;56(12):2723-32
    Jo SH et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: ChIP
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Chambers KT et al. PGC-1β and ChREBP partner to cooperatively regulate hepatic lipogenesis in a glucose concentration-dependent manner. Mol Metab 2013;2(3):194-204
    Chambers KT et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: WB, ChIP
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Wu L et al. Flightless I homolog negatively regulates ChREBP activity in cancer cells. Int. J. Biochem. Cell Biol. 2013 Nov;45(11):2688-97
    Wu L et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IP, WB
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Liu L et al. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. J Ethnopharmacol 2013 Dec;150(3):1045-52
    Liu L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Xing X et al. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver. Toxicol. Appl. Pharmacol. 2014 Oct;280(2):207-15
    Xing X et al
    2014/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Chang ML et al. High glucose activates ChREBP-mediated HIF-1α and VEGF expression in human RPE cells under normoxia. Adv. Exp. Med. Biol. 2014;801:609-21
    Chang ML et al
    2014/01/01
  • 備考:
    Species: Human, Applications: ChIP, WB, ICC/IF
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Kaadige MR et al. MondoA-Mlx Transcriptional Activity Is Limited by mTOR-MondoA Interaction. Mol. Cell. Biol. 2015 Jan;35(1):101-10
    Kaadige MR et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Gupta M et al. Maternal magnesium deficiency in mice leads to maternal metabolic dysfunction and altered lipid metabolism with fetal growth restriction. Mol. Med. 2014;20:332-40
    Gupta M et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Cort辿s VA et al. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors. J. Lipid Res. 2014 Feb;55(2):276-88
    Cort辿s VA et al
    2014/01/01
  • 備考:
    Species: Mouse,
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Bindesb淡ll C et al. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity. J. Lipid Res. 2015 Apr;56(4):771-85
    Bindesb淡ll C et al
    2015/01/01
  • 備考:
    Species: Mouse,
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Marmier S et al. Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology 2015 Mar;
    Marmier S et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB, IP
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Poungvarin N et al. Genome-Wide Analysis of ChREBP Binding Sites on Male Mouse Liver and White Adipose Chromatin. Endocrinology 2015 Jun;156(6):1982-94
    Poungvarin N et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: ChIP
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Li X et al. New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells. Mol. Endocrinol. 2015 Aug;29(8):1184-94
    Li X et al
    2015/01/01
  • 備考:
    Species: Human, Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Cha-Molstad H et al. Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells. J. Biol. Chem. 2009 Jun;284(25):16898-905
    Cha-Molstad H et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Butcher AJ et al. N-methyl-D-aspartate receptors mediate the phosphorylation and desensitization of muscarinic receptors in cerebellar granule neurons. J. Biol. Chem. 2009 Jun;284(25):17147-56
    Butcher AJ et al
    2009/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Nuotio-Antar AM et al. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance. Endocrinology 2015 Nov;156(11):4020-32
    Nuotio-Antar AM et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Ferreira DM et al. Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains. Microb. Pathog. 2009 Sep;47(3):157-63
    Ferreira DM et al
    2009/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Adamson AW et al. Hepatocyte nuclear factor-4alpha contributes to carbohydrate-induced transcriptional activation of hepatic fatty acid synthase. Biochem. J. 2006 Oct;399(2):285-95
    Adamson AW et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Pedersen KB et al. Glucose induces expression of rat pyruvate carboxylase through a carbohydrate response element in the distal gene promoter. Biochem. J. 2010 Mar;426(2):159-70
    Pedersen KB et al
    2010/01/01
  • 備考:
    Species: Rat
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Yu FX et al. Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate. J. Biol. Chem. 2010 Aug;285(33):25822-30
    Yu FX et al
    2010/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Marmugi A et al. Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way. Toxicol. Appl. Pharmacol. 2016 Jul;303:90-100
    Marmugi A et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Kitsunai H et al. High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells. Physiol Rep 2016 Mar;4(6)
    Kitsunai H et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Zhang Z et al. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. Sci Rep 2016;6:20848
    Zhang Z et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Tang Y et al. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Nat Commun 2016;7:11365
    Tang Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Witte N et al. The Glucose Sensor ChREBP Links De Novo Lipogenesis to PPARγ Activity and Adipocyte Differentiation. Endocrinology 2015 Nov;156(11):4008-19
    Witte N et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Chelimo K et al. Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1. PLoS ONE 2011;6(9):e24852
    Chelimo K et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Miller SD et al. Reduced impact logging minimally alters tropical rainforest carbon and energy exchange. Proc. Natl. Acad. Sci. U.S.A. 2011 Nov;108(48):19431-5
    Miller SD et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Krishnamoorthy N et al. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat. Med. 2008 May;14(5):565-73
    Krishnamoorthy N et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Trabelsi MS et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun 2015;6:7629
    Trabelsi MS et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Eckert DT et al. Detailed molecular analysis of the induction of the L-PK gene by glucose. Biochem. Biophys. Res. Commun. 2008 Jul;372(1):131-6
    Eckert DT et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Xiang Y et al. Crystal structure of a virus-encoded putative glycosyltransferase. J. Virol. 2010 Dec;84(23):12265-73
    Xiang Y et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Kim GY et al. Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy. Hum. Mol. Genet. 2017 05;26(10):1890-1899
    Kim GY et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Sanchez-Gurmaches J et al. Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis. Cell Metab. 2018 Jan;27(1):195-209.e6
    Sanchez-Gurmaches J et al
    2018/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Janssens S et al. An In Vivo Magnetic Resonance Spectroscopy Study of the Effects of Caloric and Non-Caloric Sweeteners on Liver Lipid Metabolism in Rats. Nutrients 2017 May;9(5)
    Janssens S et al
    2017/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Singh KB et al. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism. Carcinogenesis 2018 May;39(6):826-837
    Singh KB et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Schmidt SF et al. Integrative Genomics Outlines a Biphasic Glucose Response and a ChREBP-RORγ Axis Regulating Proliferation in β Cells. Cell Rep 2016 08;16(9):2359-72
    Schmidt SF et al
    2016/01/01
  • 備考:
    Species: Human, Applications: ChIP
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Harris K et al. The effects of prenatal metformin on obesogenic diet-induced alterations in maternal and fetal fatty acid metabolism. Nutr Metab (Lond) 2016;13(1):55
    Harris K et al
    2016/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Al-Oanzi ZH et al. Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes. Diabetes Obes Metab 2017 08;19(8):1078-1087
    Al-Oanzi ZH et al
    2017/01/01
  • 備考:
    Species: Rat, Applications: ChIP
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Bricambert J et al. The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. Nat Commun 2018 05;9(1):2092
    Bricambert J et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Linden AG et al. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J. Lipid Res. 2018 03;59(3):475-487
    Linden AG et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Fan Q et al. LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice. Nutrients 2017 Jun;9(7)
    Fan Q et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Kim YS et al. Aralia elata (Miq) Seem Extract Decreases O-GlcNAc Transferase Expression and Retinal Cell Death in Diabetic Mice. J Med Food 2017 Oct;20(10):989-1001
    Kim YS et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Cho JH et al. Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia. PLoS Genet. 2017 May;13(5):e1006819
    Cho JH et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Cao W et al. Dual effects of fructose on ChREBP and FoxO1/3α are responsible for AldoB up-regulation and vascular remodelling. Clin. Sci. 2017 02;131(4):309-325
    Cao W et al
    2017/01/01
  • 備考:
    WB
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Kumar A et al. Activation of Nrf2 Is Required for Normal and ChREBPα-Augmented Glucose-Stimulated β-Cell Proliferation. Diabetes 2018 08;67(8):1561-1575
    Kumar A et al
    2018/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Kim MS et al. ChREBP regulates fructose-induced glucose production independently of insulin signaling. J. Clin. Invest. 2016 11;126(11):4372-4386
    Kim MS et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Na TY et al. The trisaccharide raffinose modulates epidermal differentiation through activation of liver X receptor. Sci Rep 2017 03;7:43823
    Na TY et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ChIP
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Iroz A et al. A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response. Cell Rep 2017 Oct;21(2):403-416
    Iroz A et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: ChIP
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Softic S et al. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J. Clin. Invest. 2017 Nov;127(11):4059-4074
    Softic S et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Kwon JH et al. Liver-directed gene therapy for murine glycogen storage disease type Ib. Hum. Mol. Genet. 2017 11;26(22):4395-4405
    Kwon JH et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Kim M et al. Intestinal, but not hepatic, ChREBP is required for fructose tolerance. JCI Insight 2017 Dec;2(24)
    Kim M et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: ChIP, WB
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Heidenreich S et al. Retinol saturase coordinates liver metabolism by regulating ChREBP activity. Nat Commun 2017 08;8(1):384
    Heidenreich S et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Kim YS et al. Metformin protects against retinal cell death in diabetic mice. Biochem. Biophys. Res. Commun. 2017 10;492(3):397-403
    Kim YS et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications:
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Zhao C et al. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. Mol Metab 2019 11;29:145-157
    Zhao C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Irimia JM et al. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice. J Biol Chem 2017 06;292(25):10455-10464
    Irimia JM et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Long J et al. Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1. J Biol Chem 2020 11;295(47):15840-15852
    Long J et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Lei Y et al. Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation. Sci Rep 2020 03;10(1):4233
    Lei Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Fan Q et al. LXRα Regulates ChREBPα Transactivity in a Target Gene-Specific Manner through an Agonist-Modulated LBD-LID Interaction. Cells 2020 05;9(5)
    Fan Q et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    McMurphy TB et al. Hepatic Expression of Adenovirus 36 E4ORF1 Improves Glycemic Control and Promotes Glucose Metabolism Through AKT Activation. Diabetes 2017 02;66(2):358-371
    McMurphy TB et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Tong X et al. DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1. Metabolism 2020 06;107:154222
    Tong X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Bagchi DP et al. Wntless regulates lipogenic gene expression in adipocytes and protects against diet-induced metabolic dysfunction. Mol Metab 2020 09;39:100992
    Bagchi DP et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Wei C et al. ChREBP-β regulates thermogenesis in brown adipose tissue. J Endocrinol 2020 06;245(3):343-356
    Wei C et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Youn DY et al. The Mediator complex kinase module is necessary for fructose regulation of liver glycogen levels through induction of glucose-6-phosphatase catalytic subunit (G6pc). Mol Metab 2021 06;48:101227
    Youn DY et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Vel叩zquez-Villegas L et al. ChREBP downregulates SNAT2 amino acid transporter expression through interactions with SMRT in response to a high-carbohydrate diet. Am J Physiol Endocrinol Metab 2021 01;320(1):E102-E112
    Vel叩zquez-Villegas L et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    Liu Y et al. Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles. Sci Rep 2021 Jun;11(1):11907
    Liu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Lu Y et al. ERα down-regulates carbohydrate responsive element binding protein and decreases aerobic glycolysis in liver cancer cells. J Cell Mol Med 2021 04;25(7):3427-3436
    Lu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Katz LS et al. T3 and Glucose Coordinately Stimulate ChREBP-Mediated Ucp1 Expression in Brown Adipocytes From Male Mice. Endocrinology 2018 01;159(1):557-569
    Katz LS et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Mori H et al. The molecular and metabolic program by which white adipocytes adapt to cool physiologic temperatures. PLoS Biol 2021 05;19(5):e3000988
    Mori H et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    Gutierrez JA et al. Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction. Mol Metab 2021 06;48:101196
    Gutierrez JA et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    Hsiao WY et al. The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development. Cell Rep 2020 10;33(1):108223
    Hsiao WY et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Heidenreich S et al. The glucose-sensing transcription factor ChREBP is targeted by proline hydroxylation. J Biol Chem 2020 12;295(50):17158-17168
    Heidenreich S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Schlein C et al. Endogenous Fatty Acid Synthesis Drives Brown Adipose Tissue Involution. Cell Rep 2021 01;34(2):108624
    Schlein C et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Chen N et al. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy. J Diabetes Complications 2021 Dec;35(12):108050
    Chen N et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed